Yubo International Biotech annual debt-to-assets ratio
2020
2021
2022
2023
2024
2025
Yubo International Biotech Debt-to-Assets Ratio Growth & History (YBGJ)
Yubo International Biotech's debt-to-assets ratio was 0.09 for fiscal 2025.
View full Yubo International Biotech company overviewYubo International Biotech annual debt-to-assets ratio history
| Fiscal year | Period ended | Debt-to-assets ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.09 | −0.22 | −70.19% |
| 2024 | 2024-12-31 | 0.31 | 0.08 | +32.70% |
| 2023 | 2023-12-31 | 0.24 | −0.10 | −30.16% |
| 2022 | 2022-12-31 | 0.34 | 0.27 | +425.20% |
| 2021 | 2021-12-31 | 0.06 | −0.06 | −50.29% |
| 2020 · Dec 31 | 2020-12-31 | 0.13 | — | — |
Yubo International Biotech quarterly debt-to-assets ratio
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Debt-to-assets ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.02 | −0.15 | −86.76% |
| Q1 2026 | 2026-03-31 | 0.06 | −0.14 | −72.15% |
| Q4 2025 | 2025-12-31 | 0.09 | −0.22 | −70.19% |
| Q3 2025 | 2025-09-30 | 0.15 | −0.20 | −58.50% |
| Q2 2025 | 2025-06-30 | 0.18 | −0.11 | −39.09% |
| Q1 2025 | 2025-03-31 | 0.20 | 0.01 | +5.40% |
| Q4 2024 | 2024-12-31 | 0.31 | 0.08 | +32.70% |
| Q3 2024 | 2024-09-30 | 0.35 | 0.09 | +35.91% |
| Q2 2024 | 2024-06-30 | 0.29 | 0.00 | +1.00% |
| Q1 2024 | 2024-03-31 | 0.19 | −0.13 | −40.36% |
| Q4 2023 | 2023-12-31 | 0.24 | −0.10 | −30.16% |
| Q3 2023 | 2023-09-30 | 0.26 | 0.18 | +211.54% |
| Q2 2023 | 2023-06-30 | 0.29 | 0.21 | +284.60% |
| Q1 2023 | 2023-03-31 | 0.32 | 0.25 | +357.84% |
| Q4 2022 | 2022-12-31 | 0.34 | 0.27 | +425.20% |
| Q3 2022 | 2022-09-30 | 0.08 | 0.06 | +354.11% |
| Q2 2022 | 2022-06-30 | 0.07 | −0.05 | −38.67% |
| Q1 2022 | 2022-03-31 | 0.07 | 0.01 | +16.46% |
| Q4 2021 | 2021-12-31 | 0.06 | −0.06 | −50.29% |
| Q3 2021 · Sep 30 | 2021-09-30 | 0.02 | — | — |
| Q2 2021 · Jun 30 | 2021-06-30 | 0.12 | — | — |
| Q1 2021 · Mar 31 | 2021-03-31 | 0.06 | — | — |
| Q4 2020 · Dec 31 | 2020-12-31 | 0.13 | — | — |
Yubo International Biotech debt-to-assets ratio trends
Over the last five fiscal years, Yubo International Biotech's debt-to-assets ratio decreased from 0.13 to 0.09, a change of −0.04. The latest reported quarter, Q2 2026, shows 0.02.
About the metric
What the debt-to-assets ratio means
The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.
Calculation and source
How debt-to-assets is calculated
TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Yubo International Biotech source filings ↗